Suspect claims in Teva’s suit against Cipla

The US Federal Trade Commission has warned the Israeli drug firm its patents are wrongful as it sues Cipla aggressively

These lethal changes in India’s patent rules

The proposed amendments are a capitulation to Big Pharma and will undermine vital public health safeguards in the law

Gilead granted patent for hepatitis C drug Solvadi

The move is being seen as a possible impact of Indian Prime Minister Narendra Modi’s proposed visit to the US next month

More Indian residents filing patents than MNCs despite challenges: Economic Survey

India still lags behind China, the United States, Japan and South Korea despite an increase in the number of patents being filed

Lethal hypocrisy of US Special 301 Report

Patent protection in the US is a convoluted and expensive business and yet it pulls up other countries that have robust systems

Why Modi's razzmatazz diplomacy isn't serving African interests

Missing from Modi’s foreign trips is a focus on issues most pressing for Africa’s people

Getting the drug equation right

Sonal Matharu reports how fights over counterfeit drugs and low-quality drugs is suppressing the larger issue of drug safety